Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Acta Neuropathol. 2019 Oct 31;139(3):527–546. doi: 10.1007/s00401-019-02085-x

Table 1.

Human cases used for heparan sulfate analysis.

Code Age
of
onset
Disease
duration
(months)
Gender PRNP
genotype
(mutation-
129codon)
PrPSc subtype Symptoms at
disease onset
Family
history of
prion
disease
1 49 120 M F198S-129MV GSS, 8 kDa Cerebellar Brother and niece
2 51 72 M F198S-129VV GSS, 8 kDa Cerebellar Brother and daughter
3 60 89 M F198S-129MV GSS, 8 kDa Not reported Father
4 67 63 M F198S-129MV GSS, 8 kDa Not reported Not reported
5 22 23 M P102L-129MV fCJD, Type 1 Seizures Cousin
6 60 20 M 129MV sCJD, Type intermediate+ 2 Visuospatial Not reported
7 55 6 F 129VV sCJD, Type 2 Apraxia Not reported
8 55 24 F 129MV sCJD, Type intermediate+ 2 Behavior Not reported
9 69 6 F 129MV sCJD, Type 1 Behavior/Memory Not reported
10 60 1.5 M 129MM sCJD, Type 1 Cognitive/Visual Not reported
11 57 4 F 129MM sCJD, Type 1 Motor Not reported